September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the intellectual property and technology assets of LindaCare, a digital health company specializing in remote monitoring.
September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY Mapping Catheter with TRUEref Technology powered by the CARTO 3 Version 7 System.
September 7, 2022 —  Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid overload, announced the publication of key clinical data supporting the use of ultrafiltration with theÂ
September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measurable impact on vascular health. The study compared the impact on the health of people living in a partial vs. a total lockdown during the beginning of COVID-19. Â
Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and interventional cardiology during the month of August:
September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life. That’s the finding of a modelling study presented at ESC Congress 2022.1Â
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 The study found that the more people smoked, the worse their heart function became.